Abstract. There is currently no suitable animal model of metastasis using cultured human gastrointestinal stromal tumor cells even though the molecular mechanisms of c-KITmediated progression and metastasis should be clarified.
Introduction
Human gastrointestinal stromal tumors (GISTs), which are mesenchymal tumors of the gastrointestinal tract, are believed to originate from a neoplastic transformation of interstitial cells of Cajal and often express gene mutation to c-KIT (1) . The mutation of c-KIT contributes to constitutive activations of itself and the downstream effectors which play an important role in cell proliferation and survival, thereby accelerating malignant progression (2) . It is also reported that the KIT mutation-positive GISTs showed more frequent liver metastases and higher mortality than KIT mutation-negative GISTs (3), although the detailed mechanism of c-KIT-mediated cell migration and metastasis has not been characterized. Molecular-based research on GIST has been facing some difficulties to be explored, partially because at the moment, there is no study regarding any suitable animal models with peritoneal dissemination or liver metastasis using cultured human GIST cells, giving the impression that it is difficult to establish a metastasis model of GIST.
Ba/F3 murine lymphocyte-derived cell lines, which can only grow under the existence of IL-3, proliferate independent of IL-3 by stably transducing mutant c-KIT genes that are often found in clinical GIST cases (4) (5) (6) . These derivatives have been utilized to analyze some molecular mechanisms related to a constitutively activated c-KIT signaling (4) (5) (6) (7) (8) and to assess the efficacy of molecular-targeted inhibitors such as Imatinib and Sorafenib (9, 10) . Using this cellular system, it has been reported that Ba/F3 cells with c-KIT mutation can form a subcutaneous tumor in nude mice (6, 9) and have been utilized in some investigations to help understand the molecular aspects of c-KIT mutation and its relationship to tumor progression (4, 6, 9) . Herein we report that we coincidentally discovered the development of axillary and inguinal lymph node swelling three weeks after subcutaneous injection of 
Materials and methods
Cell lines and cultures. Ba/F3 derivatives, stable transfectants with mutant c-KITs in original murine lymphocytes (Ba/F3), were generous gifts by Dr Seiichi Hirota (Hyogo College of Medicine, Nishinomiya, Japan) and were used in this study.
The three types of c-KIT mutation used in this study are as described previously (4) (5) (6) (7) . Briefly, KIT del559-560 represents an in-frame deletion of 6 bps encoding Val-559-Val-560 in the juxtamenbrane domain, KIT 642Glu is a Lys-to-Glu substitution at codon 642 in the tyrosine kinase (TK) I domain and KIT 820Tyr is an Asp-to-Tyr substitution at codon 820 in the TK II domain. These cell lines were cultured in · Modified Eagle Medium (·MEM) (MP Biomedicals, LLC, Solon, OH) supplemented with 10% fetal bovine serum (FBS) (Invitrogen Co., Carlsbad, CA) and maintained in culture at 37˚C in humidified air with 5% CO 2 .
Animal experiments. All mouse experiments were carried out in accordance with the standards and guidelines of the Department of Animal Resources at Okayama University and followed principles of laboratory animal care (NIH publication No. 85-23, revised 1985). Eight week-old female BALB/ cAjcl-nu/nu mice derived from C.B-17/Icr (Clea, Tokyo, Japan) were used in this study. All mice were maintained under pathogen-free conditions. When the cells were propagated enough, they were collected as a pellet by a five minute-centrifugation at 3000 rpm and were resuspended with growth media to make a suspension of 5x10 6 cells in 100 μl. The cell suspension was mixed with Matrigel (BD Biosciences, San Jose, CA) at a 1:1 ratio and 200 μl of the final mixture was injected subcutaneously near the iliac bone in the right back of an anesthesized mouse. Three weeks later, the mice were sacrificed for observation and resection of tissues.
Reverse transcription-polymerase chain reaction (RT-PCR).
Total RNA was prepared by RNAzol (Tel-Test, Inc., USA) from tissues resected from the mice. An input of 1 μg total RNA was reverse transcribed with a PrimeScript 1st strand cDNA synthesis kit according to the manufacturer's instructions (Takara Biotechnology Co. Ltd., Japan).
Subsequent PCRs were carried out to specifically detect the del559-560 type of c-KIT mutation using KOD plus DNA polymerase (Toyobo Co. Ltd., Osaka, Japan) and the following set of primers; forward: 5'-gta caa tgg aag gag gag ata aat gg-3', reverse: 5'-tct tgc gga tct cct ctt gt-3'. For c-KIT cDNA amplification, an initial denaturation at 94˚C for 10 min was followed by 35 cycles of a denaturation step at 94˚C for 30 sec, an annealing step at 60˚C for 45 sec and an extension step at 68˚C for 1 min. The amplified 558-bp products were electrophoresed in 1% agarose gel for visualization in a UV-transilluminator.
Immunohistochemistry. Resected tissues were fixed with 10% formalin and paraffinized for sectioning. Embedded 5-μm sections on silanized slides were subjected to immunohistochemical staining following a procedure described previously (11) . Briefly, after endogenous peroxidase activity was blocked using 3.0% H 2 O 2 in methanol for 15 min, antigen retrieval was performed by heating in 10 mm citrate buffer solution (pH 6.0), followed by blocking of nonspecific reactivity with rabbit serum. Overnight-incubation with a primary antibody at 4˚C and subsequent labelings with a biotinylated anti-primary antibody and streptavidin peroxidase were performed before visualization. Color development was achieved using DAB/H 2 O 2 solution (Histofine DAB substrate kit; Nichirei) and Mayer's hematoxylin as counterstaining. Some sections were subjected to normal serum blocking and omission of the primary antibody as a negative control. The primary antibody used in this study was anti-Ki-67 (clone MIB-1) monoclonal antibody (Dako Cytomation A/S, Copenhagen, Denmark).
Results and Discussion
Macroscopic views of the lymph node swelling on the 21st day after subcutaneous injection of tumor cells. When Ba/F3 derivatives were subcutaneously inoculated into nude mice, all of them formed tumors on the inoculated sites. While the subcutaneous tumors were growing, macroscopic swelling of the lymph nodes at the axillary and inguinal lesions was eventually recognized 21 days from the date of cell injection (Fig. 1) . Surgical observation by opening the skin of the mice showed an obvious existence of lymph node swelling in those areas with a certain distance from the original tumor on the back. Of note, the axillary lymph nodes were recognized by their milky white tone, whereas the inguinal lymph nodes were colored a reddish brown. We confirmed that all of tumorbearing mice revealed swollen lymph nodes both in axillary region and in inguinal region and each region contained 1 or 2 swollen masses (Table I ). This observation tempted us to speculate that the swelling of the lymph nodes may have been due to metastasis from the subcutaneous tumors.
Microscopic observation of primary subcutaneous tumors.
When hematoxylin and eosin staining was applied to paraffin sections of resected tissues, each of the subcutaneous tumors was filled with tumor cells, which exhibited a large N/C ratio regardless of c-KIT mutation type (Fig. 2) . Microscopic Table I . Incidence of lymph node swelling in Ba/F3 subcutaneous xenograft. ------------------------------------------------- observation of the swollen lymph nodes indicated that tumor cells, which looked the same as the ones in the primary subcutaneous tumors, occupied most of the swollen lymph nodes and that the remaining lymphocytes maintained a margin of the mass (Fig. 3) . This finding suggested that the swelling of these lymph nodes may have been caused by the infiltration of tumor cells from the original subcutaneous tumors.
-------------------------------------------------Sites of lymph nodes ---------------Cell line Mutation site Axillary Inguinal -------------------------------------------------

Detection of c-KIT mutation in the swollen lymph nodes as a direct proof of lymph nodal metastasis.
To get a direct evidence that the swollen lymph nodes were occupied with metastasized tumor cells, RT-PCR was carried out to specifically detect c-KIT mutation which should be originated from the primary subcutaneous tumors but not from any other sites nor from de novo neoplasms. Fig. 4 exhibited an apparent detection of deletion-type mutation of c-KIT in a swollen lymph node that was taken out of a mouse bearing a subcutaneous tumor of Ba/F3-c-KIT del559-560 cells. This result supported our observation that Ba/F3 derivatives with mutant c-KIT indeed infiltrated into the axillary and inguinal lymph nodes and that this locomotion was a metastasis from the original subcutaneous tumors.
Indirect proof of tumor cells in swollen lymph nodes with close attention to the difference of growth abilities.
We further assessed the ability of proliferation in metastasized tumor cells in swollen lymph nodes to support our observation of regional lymph node metastasis. Immunohistochemical staining for Ki-67, a marker for active proliferation, was used to distinguish tumor cells, which have a potent ability to grow, from lymphocytes, because lymphocytes should be terminally differentiated and are usually quiescent in their growth status. As shown in Fig. 5 , more Ki-67-positive staining was detected in the swollen lymph nodes than in normal lymph nodes and the positive staining was observed in the swollen lymph nodes corresponding to tumor cells with a large N/C ratio. Statistical analysis revealed that the positive-stained cells were significantly more in swollen lymph nodes than in normal lymph nodes (Fig. 5e) . On the other hand, there was no positive staining in the lymphocytes adjacent to the tumor cells ( Fig. 5a and b) . A subset of positive-stained cells were observed at the center of normal lymph nodes though, we assumed that they might be metrocytes such as stem cells (Fig. 5c and d) . active c-KIT signaling (4) (5) (6) (7) (8) and to assess the efficacy of molecular-targeted inhibitors (9, 10) . In this study, we successfully established a model that Ba/F3 cells transduced with c-KIT mutation metastasized from the original subcutaneous site to the lymph nodes. Parental Ba/F3 cells, which grow dependent of IL-3 with intact c-KIT, cannot form subcutaneous tumors (6, 9) . On the other hand, once the cells are exogenously transduced with mutant c-KIT, the cells can grow even without IL-3 (6) and develop tumors on the backs of nude mice, followed by metastatic swelling of the lymph nodes. This suggests that a constitutive activation of c-KIT causes an increased ability of tumor growth and cell motility. The significance of this model is that it helps to understand the molecular mechanisms of c-KIT-mediated metastasis and that it may be useful to assess chemotherapeutic effects of compounds targeting c-KIT signaling, since upregulation of c-KIT is observed as a subset of malignant melanoma (12, 13) and small cell carcinoma of the lung (14) in addition to GISTs. It should be noted that cell growth is faster in the following order: KIT del559-560 > KIT 642Glu > KIT 820Tyr (9) and that the lymph node swelling also tends to appear according to the same order. Since the only difference of molecular background between those cells was the type of c-KIT mutation, the status of c-KIT mutation and its activity could be closely related with the potential of tumor progression and mortality in this metastasis model.
In conclusion, we have established a promising model that Ba/F3 cells with mutant c-KIT genes, which are often observed in clinical GIST cases, can be metastasized from a primary subcutaneous tumor to the axillary and inguinal lymph nodes in three weeks. We expect that this model is useful to understand the molecular mechanisms of c-KIT-mediated tumor progression and metastasis in vivo.
